Found: 14
Select item for more details and to access through your institution.
A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1421, doi. 10.1007/s10637-020-00899-1
- By:
- Publication type:
- Article
ASO Perspectives: Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer: Never Stop Questioning.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Correction: Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice
Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis.
- Published in:
- Clinical & Translational Gastroenterology, 2018, v. 9, n. 9, p. 1, doi. 10.1038/s41424-018-0049-9
- By:
- Publication type:
- Article
Pneumatosis intestinalis in cancer patients who received immune checkpoint inhibitors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 19, p. 17597, doi. 10.1007/s00432-023-05461-z
- By:
- Publication type:
- Article
Chemotherapy and Radiation Versus Chemotherapy Alone for Elderly Patients With N3 Stage IIIB NSCLC.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.984940
- By:
- Publication type:
- Article
Phase II Trial of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 4, p. 770, doi. 10.1002/cncr.22857
- By:
- Publication type:
- Article
High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 127, doi. 10.3390/cancers12010127
- By:
- Publication type:
- Article
Confirmatory DPYD Testing in Patients Receiving Fluoropyrimidines Who are Suspected DPYD Variant Carriers Based on a Genetic Data Repository.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 356, doi. 10.1002/cpt.2936
- By:
- Publication type:
- Article
Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13236-8
- By:
- Publication type:
- Article
Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung cancer.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Phase II Trial of Imatinib Maintenance Therapy After Irinotecan and Cisplatin in Patients With c-Kit–Positive, Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2010, v. 11, n. 4, p. 223, doi. 10.3816/CLC.2010.n.028
- By:
- Publication type:
- Article